The AI rewriting medicine is the same AI now applied to 47 years of quant investing data — and the backtested results are extraordinary.

Many investors think of AI as a story about chips, software, and the companies building the technology. But its biggest impact may be far broader than that. My colleague Louis…

The AI rewriting medicine is the same AI now applied to 47 years of quant investing data — and the backtested results are extraordinary.